Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by rtftech16on Oct 13, 2017 1:23pm
260 Views
Post# 26810824

RE:RE:RE:RE:strong rumour on bay st

RE:RE:RE:RE:strong rumour on bay stToronto market just started its downtrend. It takes 6-8 years before you see pricing go back down to the average growth level. Pharma assets are way more volatile than housing prices. They had more rapidly inflated price growth compared to real estate. They will fall even faster. 1-3 years pharma assets will be dirt cheap from pharma companies selling who went in massive debt (they actually overpaid to be in debt: funny how you can't see your in a bubble when your in one). They cannot sustain those levels of debt and eventually sell non-core AND core assets for cheap, especially when faced with bankruptcy. This is when GUD will strike. Its a simple strategy that takes patience; apparently the most difficult attribute to successfully implement in ones life. This is what makes Goodman, Buffet, Munger etc all better than the rest. Remember that hardly any portfolio managers can touch this stock until it reaches a certain price point ($20-25 level usually). Once GUD reaches past this the growth will be rapid as everyone jumps on board. This will inflate the stock price quickly (which you are all waiting for). It will hit $40-50 quick and this is when a lot of you will jump off board due to impatience (even though you will have made a beautiful profit). This creates another buying opportunity for those of us going to the top with Goodman (150+ / share). GLTA
Bullboard Posts